Joyance Partners
VC Fund
San Francisco, United States
Joyance Partners is a VC fund in San Francisco focused on Health Care and Biotechnology. Joyance Partners invests in companies that, through science and tech, cultivate joy to improve how we live, focusing on the health and consumer sectors from Pre-Seed to Series A.
- Total investments:
- 121
- Last investment:
- Lead investor:
- 7%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Joyance Partners invests in
Stages Joyance Partners invests in
Countries Joyance Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Seed
- $960k–$6M
- Pre-Seed
- $500k–$2M
- Series A
- $3.6M–$18M
Investment Focus
Industry
- Health Care 42 (35%)
- Biotechnology 23 (19%)
- Wellness 18 (15%)
- Food and Beverage 17 (14%)
- Artificial Intelligence 12 (10%)
Stage
- Seed 53 (44%)
- Series A 20 (17%)
- Pre-Seed 13 (11%)
- Funding Round 7 (6%)
- Convertible Note 7 (6%)
Country
- United States 54 (45%)
- Germany 8 (7%)
- Switzerland 5 (4%)
- United Kingdom 5 (4%)
- Japan 4 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Holly Jacobus
Investment Partner
|
Investment Partner | Total investments: 2 | Find email | |
|
Andrew Nealon
Chief Analyst
|
Chief Analyst | Total investments: 0 | Find email | |
|
Charles Smith
Venture Partner
|
Venture Partner | Total investments: 10 | Find email | |
|
Charles Smith
Venture Partner
|
Venture Partner | Total investments: 12 | Find email | |
|
Claire Cherry
Investment Partner
|
Investment Partner | Total investments: 5 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Siena AI is a developer of an autonomous chat platform that aims to transform the way it runs and interacts with consumers by combining human empathy and intelligent automation. The platform provides capabilities such as product information, order tracking, address changes, returns and product exchanges, subscription and retention management,allowing firms to conduct customer care and social media interactions autonomously. | $17M / Series A / Oct 06, 2026 | ||
| KilgourMD develops hair and scalp care products for reducing shedding and supporting scalp health. They formulate topical serums and treatment solutions. Their products address hair loss prevention and scalp maintenance. | Series A / Mar 26, 2026 | ||
| LUCKY F*CK is a better-for-you energy drink company. | $25M / Series B / Nov 11, 2025 | ||
| NOMU provides the personalized drinking experience with its proprietary reusable cup drink machine. | $3M / Seed / Oct 15, 2025 | ||
| KilgourMD develops hair and scalp care products for reducing shedding and supporting scalp health. They formulate topical serums and treatment solutions. Their products address hair loss prevention and scalp maintenance. | $5M / Seed / Oct 15, 2025 | ||
| Japan Culture and Technology assists artists and craftspeople in expanding their activities by providing IT support. | $7.8M / Series B / May 15, 2025 | ||
| Epicore Biosystems develops a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance ,and nutrition. Epicore's wearable sensing technology is based on over twodecades of microfluidics and soft materials research by Prof. John Rogers and Dr. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Bioelectronics. | $6M / Series B / May 01, 2025 | ||
| PostCoffee is an online coffee platform that provides coffee subscription and delivery services. | Venture - Series Unknown / Feb 25, 2025 | ||
| Millie is a new kind of maternity clinic. Built by moms and providers who’ve been there. | $12M / Series A / Feb 20, 2025 | ||
| DAMDAM is clean skincare born from Japanese craftsmanship and time-honored plant ingredients. We believe in creating thoroughly modern, thoughtfully made products that cultivate a connection between ourselves and the natural world. The line is minimal, made up of purposeful essentials formulated to work alone or in harmonious combination with eachother. All products are made with 100% natural ingredients that have high efficacy without causing irritation. Equally important, they feel weightless on skin. | $3M / Seed / Jan 28, 2025 | ||
| See all 121 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Joyance Partners invest in?
Joyance Partners invests primarily in Health Care, Biotechnology and Wellness startups, most often at Seed and Series A stage. Most of the 121 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Joyance Partners invest in?
Joyance Partners typically joins rounds of $960k–$6M at Seed, $500k–$2M at Pre-Seed and $3.6M–$18M at Series A. These are whole funding-round sizes, not Joyance Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Joyance Partners took part in.
How do I contact Joyance Partners?
Public channels for Joyance Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Joyance Partners?
The team at Joyance Partners includes Holly Jacobus (Investment Partner), Andrew Nealon (Chief Analyst) and Charles Smith (Venture Partner), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!